The iPSC haplobank provides standardized, high-quality pluripotent stem cell lines representing diverse HLA haplotypes. These banks reduce immune rejection risks, accelerate clinical translation, and streamline manufacturing by offering readily available, GMP-grade starting materials for cell and gene therapy research and therapeutic development. https://xelleratherapeutic.wixsite.com/xellera-therapeutics/post/how-ipsc-haplobank-supports-allogeneic-cell-therapies